STOCK TITAN

NAUT: Perceptive’s 12.8M-Share Holding Intact as Director Steps Down

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. filed Amendment No. 4 to Schedule 13D for Nautilus Biotechnology, Inc. (NAUT) on 24 June 2025. The filing discloses that the reporting group continues to hold 12,815,113 common shares, equal to 10.1 % of NAUT’s 126,148,469 shares outstanding as reported in the company’s 29 April 2025 proxy statement. The position is held on a shared voting and dispositive basis; none of the reporting persons has sole power over the shares.

The stake includes 220,902 shares underlying stock options granted to Michael Altman, a Perceptive Managing Director whose related director compensation is offset against Master Fund fees. Importantly, Mr. Altman ceased serving on Nautilus’s board effective 20 June 2025 when his term expired and he did not stand for re-election. No changes to share ownership levels were reported in this amendment—its primary purpose is to reflect the board-service change and update ownership calculations to the latest outstanding-share figure.

Key takeaways for investors:

  • The Perceptive group remains a double-digit owner, preserving potential influence through its economic stake even after losing direct board representation.
  • The departure of Perceptive’s board designee may reduce the group’s informational access and governance leverage.
  • No purchase or sale of NAUT shares is disclosed; percentages changed only because the outstanding-share count was updated.

Positive

  • Perceptive group retains a significant 10.1 % stake, indicating continued financial commitment to NAUT.
  • No share sales disclosed; ownership stability may reassure investors about insider confidence.

Negative

  • Loss of Perceptive’s board representation reduces the shareholder group’s direct influence over corporate strategy.
  • No new capital infusion or constructive actions were announced, limiting immediate positive catalysts.

Insights

TL;DR – Perceptive keeps 10 % stake but loses its board seat; influence shifts from formal governance to pure ownership.

The amendment is governance-focused rather than transactional. Perceptive’s Managing Director Michael Altman stepped off Nautilus’s board on 20 June 2025, meaning the shareholder group no longer has direct representation. While the economic stake (12.8 M shares, 10.1 %) is unchanged, loss of a seat lowers its capacity to shape strategy or access inside information under board confidentiality protections. From a stewardship lens, this weakens the shareholder-alignment narrative that often accompanies activist or strategic investors. Still, retaining >10 % keeps Perceptive a Schedule 13D filer with potential to influence via shareholder proposals or future solicitations.

TL;DR – No buying/selling; neutral-to-slightly negative optics due to board exit, but position size unchanged.

Because no shares were traded, the filing lacks direct price-moving data. The 10 %+ holding remains an important signal of long-term confidence, yet markets may view the relinquished board seat cautiously—potentially implying reduced strategic engagement. The 10.1 % ownership is calculated against the latest share count, so percentage drift, not transactions, explains any change. Overall share-supply dynamics and float are unaffected. I view the filing as modestly negative on governance optics but not materially impactful to near-term valuation.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:06/24/2025
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:06/24/2025
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:By Perceptive Advisors LLC, by Joseph Edelman, Managing Member
Date:06/24/2025

FAQ

How many Nautilus Biotechnology (NAUT) shares does Perceptive Advisors now own?

The group reports 12,815,113 common shares, representing 10.1 % of shares outstanding.

Did Perceptive Advisors buy or sell any NAUT shares in this amendment?

No. The amendment shows no change in share count; ownership percentages were updated only for the new share-outstanding figure.

Why was the Schedule 13D/A filed on 24 June 2025?

It reflects that Michael Altman left Nautilus’s board on 20 June 2025 and updates ownership calculations.

Does Perceptive Advisors still influence Nautilus after losing the board seat?

While the board seat is gone, Perceptive’s 10 % stake still provides leverage through shareholder voting and potential future engagements.

What percentage of Nautilus does the Perceptive Life Sciences Master Fund alone hold?

The Master Fund alone reports 12,649,253 shares, equal to 10.0 % of the company.